Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 26, 2023

SELL
$98.98 - $115.74 $142,333 - $166,434
-1,438 Reduced 23.7%
4,630 $535,000
Q2 2023

Jul 26, 2023

SELL
$96.34 - $112.38 $204,529 - $238,582
-2,123 Reduced 25.92%
6,068 $624,000
Q1 2023

Apr 19, 2023

SELL
$107.32 - $113.5 $295,344 - $312,352
-2,752 Reduced 25.15%
8,191 $893,000
Q4 2022

Jan 26, 2023

SELL
$62.39 - $113.8 $894,485 - $1.63 Million
-14,337 Reduced 56.71%
10,943 $0
Q3 2022

Nov 17, 2022

SELL
$58.92 - $84.67 $494,869 - $711,143
-8,399 Reduced 24.94%
25,280 $1.56 Million
Q2 2022

Aug 09, 2022

SELL
$79.4 - $116.36 $499,108 - $731,438
-6,286 Reduced 15.73%
33,679 $2.69 Million
Q1 2022

May 03, 2022

BUY
$86.42 - $109.81 $166,012 - $210,945
1,921 Added 5.05%
39,965 $4.2 Million
Q4 2021

Feb 08, 2022

BUY
$98.56 - $119.91 $125,565 - $152,765
1,274 Added 3.46%
38,044 $4.1 Million
Q3 2021

Oct 19, 2021

BUY
$91.91 - $110.37 $275,546 - $330,889
2,998 Added 8.88%
36,770 $4.03 Million
Q2 2021

Jul 23, 2021

BUY
$86.24 - $95.92 $649,387 - $722,277
7,530 Added 28.69%
33,772 $3.16 Million
Q1 2021

Apr 23, 2021

BUY
$71.83 - $95.48 $1.7 Million - $2.26 Million
23,621 Added 901.22%
26,242 $2.42 Million
Q4 2020

Jan 29, 2021

BUY
$67.0 - $84.39 $670 - $843
10 Added 0.38%
2,621 $191,000
Q3 2020

Oct 22, 2020

SELL
$55.23 - $79.93 $102,175 - $147,870
-1,850 Reduced 41.47%
2,611 $202,000
Q2 2020

Jul 14, 2020

BUY
$30.2 - $56.98 $126,991 - $239,600
4,205 Added 1642.58%
4,461 $247,000
Q1 2020

Apr 17, 2020

BUY
$24.87 - $38.56 $497 - $771
20 Added 8.47%
256 $7,000
Q4 2019

Jan 21, 2020

SELL
$25.43 - $36.67 $762 - $1,100
-30 Reduced 11.28%
236 $8,000
Q3 2019

Oct 28, 2019

BUY
$23.0 - $27.97 $5,290 - $6,433
230 Added 638.89%
266 $7,000
Q2 2019

Jul 12, 2019

BUY
$22.81 - $28.48 $821 - $1,025
36 New
36 $0

Others Institutions Holding HZNP

About Horizon Therapeutics Public Ltd Co


  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Central Trust CO Portfolio

Follow Central Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Central Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Central Trust CO with notifications on news.